Introduction {#Sec1}
============

Lung cancer is the most common cause of death due to cancer in Japan. In [@CR30], the lung cancer screening rate was 23%, and 50,395 males and 19,418 females died from lung cancer, which accounts for more than 1 in 17 deaths (Statistics and Information Department, Minister's Secretariat, Ministry of Health, Labour and Welfare [@CR24]). Lung cancer screening using computed tomography (CT) has been carried out in Japan and the U.S. since 1993 (Kaneko et al. [@CR15]), (Henschke et al. [@CR10]). Many previous reports have indicated that CT is a good screening tool for the detection of small lung carcinomas. A high survival rate has been reported for cases of lung cancer detected with CT compared to chest radiography (Diederich et al. [@CR7]), (Jett [@CR14]), (Libby et al. [@CR17]), (Henschke et al. [@CR11])-(Toyoda et al. [@CR29]), (Fujikawa et al. [@CR8]). However, it has been reported that low-dose CT screening for lung cancer may not significantly reduce the risk of advanced lung cancer or death from lung cancer (Bach et al. [@CR2]). In November [@CR30], the National Lung Screening Trial (NLST) reported from initial trial results in the U.S. that 20% fewer lung cancer deaths were seen in trial participants that were screened with low-dose helical CT compared to those who were screened with chest X-rays (National Lung Screening Research Team [@CR20]). The results of this trial provided direct evidence of the benefits of low-dose helical CT screening in an older, high-risk population with the habit of cigarette smoking. Issues discussed concerning low-dose CT include the high dose delivered per examination, cost, radiation exposure and image quality. However, low-dose CT screening may benefit individual at an increased risk for lung cancer, but uncertainly exists about the potential of screening and the generalizability of results (Bach et al. [@CR3]).

Current studies have shown that not all pulmonary nodules detected by low-dose CT for lung cancer screening are malignant, and low-dose CT results in over-diagnosis caused by false-positive detection (Swensen et al. [@CR26]), (Croswell et al. [@CR6]). A previous report proposed that CT screening for lung cancer should be performed as a baseline. If detection of non-calcified nodules smaller than 5.0 mm in diameter is possible, a repeated annual screening, and not immediate work-up, would be justified in order to determine whether interim growth has occurred (Hensckle et al. [@CR12]). On the other hand, previous reports have indicated that thin-section CT (TSCT) and high-resolution diagnostic CT may be helpful in differentiating small malignant nodules from benign nodules (Li et al. [@CR16]), (Nakashima et al. [@CR18]). Since small nodules are very difficult to identify, periodic follow-up examinations are required for diagnosis that take into account tumor doubling time (Aoki et al. [@CR1]). Over 70% of participants had at least one follow-up CT. Non-calcified nodules are common among CT-screened high-risk subjects and can often be managed conservatively (Greenberg et al. [@CR9]).

According to a questionnaire conducted by the Japanese Society of Medical Checkups, low-dose CT screening was conducted in only 30% institute in 2008 (Takizawa [@CR28]). This may be because low-dose CT is generally recognized to create low quality images. The aim of this study was to compare images and radiation doses between low-dose for lung cancer screening and follow-up standard diagnostic CT in order to evaluate the efficacy of low-dose CT for lung cancer screening compared to repeated follow-up CT examinations.

Materials and methods {#Sec2}
=====================

Design {#Sec3}
------

In the present study, a database of low-dose CT images acquired for lung cancer screening and follow-up standard diagnostic CT images in the same patients were obtained from a single hospital. Diagnoses of lung cancer resulting from baseline low-dose CT screening and follow-up standard diagnostic CT are shown in Table [1](#Tab1){ref-type="table"}. Results from the present study including two-year follow-up data are shown. The first nodule included was from May 2008 and the last was from August [@CR30]. A total of 19 subjects who were examined with low-dose CT for lung cancer screening before going through follow-up standard diagnostic CT were randomly selected within 4 months of baseline screening. The 19 subjects (mean age, 60.6 years; age range 45--82 years) included a total of 9 men (mean age, 61.9 years; age range, 45--82 years) and 10 women (mean age, 58.8 years; age range, 49--66 years). Among the 19 subjects, 11 nodules were found in 1 subject, four nodules were found in 2 subjects, three nodules were found in 1 subject, and seven nodules were found in 1 subject.Table 1**Lung cancer diagnoses from baseline low-dose CT screening and follow-up standard diagnostic CT**Subject numberAgeSexNumber of pulmonary nodulesDays after diagnosisNodule diameter by low-dose CT (mm)Nodule diameter by follow-up diagnostic CT (mm)Diagnosis157M1431515Malignant nodule (adenocarcinoma as pure GGO with multiloculated cystic lesions )246M1151313Malignant nodule (pleural dissemination of adenocarcinoma as solid nodule with spiculation)360F24815 -- 1615 -- 16Two malignant nodules (bronchiolalveolar carcinomaı466F734 -- 74 -- 7All benign nodules570M32566All benign nodules660M4383 -- 83 -- 8Benign nodules761F14166Benign nodule859F4274 -- 74 -- 8All benign nodules982M24414 -- 1713 -- 16Possibly benign nodule, benign nodules1053F1401210Benign nodule1165F1351110Possibly benign nodule1249F17465Benign nodule1377M112098Benign nodule1460M21194 -- 74 -- 8All benign nodules1559F21204 -- 74 -- 6All benign nodules1661F111877Benign nodule1745M111768Benign nodule1864M112098Benign nodule1957F15999Possibly benign nodule

Image sets from the low-dose CT and follow-up CT of all 19 subjects were evaluated by five specialized physicians using 11 criteria related to malignancy that were developed for this study. All images were assessed independently by four radiologists with 31, 27, 21, and 8 years of experience in general radiology and a pulmonologist with 25 years of experience. Each image was ranked according to four-point confidence scales. Images were presented on a LSC 1 M monitor (EIZO Co. Ltd., Ishikawa, Japan) at a width and level of 1600 HU and −600 HU, respectively. The scales consisted of four sizes used to classify the lesions (20 ≤ S, 10 ≤ S \< 20, 5 ≤ S \< 10, S \< 5), and four patterns of typical tumor appearance (solid nodule, mixed ground-glass opacity (GGO) or solid nodule and GGO, pure GGO, or cavitary). A total of four categories of calcifications were used (present, probably present, probably absent, absent), four categories of boundaries (irregular with spiculation, slightly irregular with spiculation, somewhat smooth, smooth), four categories of shapes (round, oval, polygonal, complex), four categories of margins (irregular with spiculation, somewhat irregular with slight spiculation, somewhat smooth, smooth), four categories of spiculations (present, probably present, probably absent, absent), four categories of glomerulus, four indrawn pleura signs, and four categories of air bronchogram (present, probably present, probably absent, absent). The combined diagnostic results of low-dose screening CT or follow-up standard diagnostic CT were then assigned a score as follows: 1, annual low-dose screening with CT is recommended; 2, suspicion of a noncancerous lesion and a follow-up CT in a hospital is recommended; 3, cancer or a noncancerous lesion is suspected; and 4, cancer is suspected.

Diagnosis concordance rates between low-dose CT and follow-up standard diagnostic CT were analyzed for 37 nodules. Diagnostic low-dose CT screening and follow-up standard diagnostic CT provided information concerning only nodules position. Correlation between low-dose CT for lung cancer screening and follow-up standard diagnostic CT of the lung was obtained by means of the chi-square test for independence.

CT Techniques and procedures {#Sec4}
----------------------------

All CT was performed on a MDCT scanner (16-slice Toshiba Medical Systems Activion) at a single institution. Low-dose CT screening was obtained with the following technical parameters: 120 kV peak, 30--50 mA, a detector thickness of 1 mm, an X-ray tube rotation speed of 0.75 s, 1 mm collimation × 16 mm, and a pitch factor of 1.438 mm within one breath-holding period. Reconstruction slice thickness was 3 mm and the slice interval was 3 mm. Follow-up standard diagnostic CT was obtained with the following technical parameters: 120 kV peak, AEC (max, 150 mAs) and detector thickness 1 mm, an X-ray tube rotation speed of 0.75 second, 1 mm collimation × 16 mm, and a pitch factor of 1.188 mm within one breath-holding period. Reconstruction slice thickness was 1 mm, and the slice interval was 1 mm with a CT reconstruction algorithm. Low-dose CT screening and follow-up standard diagnostic CT was performed with only a front view scanogram. The protocols used for scanning and reconstruction for the low-dose screening CT and follow-up standard diagnostic CT are shown in Table [2](#Tab2){ref-type="table"}.Table 2**Scanning and reconstruction protocols of the toshiba MDCT scanner**Low-dose CT scanFollow-up standard diagnostic CT scanNumber of detectors1616kVp120120mA30--50CT-AEC (SD = 70)Seconds/rotation0.750.75mAs22.5--37.5Max 150Pitch factor1.4381.188Collimation1 mm × 161 mm × 16Reconstruction  slice thickness (mm)31  slice interval (mm)31Lung field1600/-6001600/-600Mediastinal400/35400/35FunctionFC52FC53

Dose estimates {#Sec5}
--------------

Tissue doses and effective doses of low-dose CT screening and follow-up standard diagnostic CT were estimated by the dose computational calculators, WAZA-ARI (Takahashi et al. [@CR27]), (Ban et al. [@CR5]), ImPACT (Imaging Performance Assessment of CT scanners) ([@CR13]) and CT-EXPO v1.7.1 (Stamm & Nagel [@CR23]). Dose calculation in WAZA-ARI utilizes the Japanese voxel phantom, where the Monte Carlo calculations are performed using the Particle and Heavy Ion Transport code System (PHITS).

Results {#Sec6}
=======

Each of the five physicians analyzed 37 nodules in 19 subjects obtained by low-dose CT screening and follow-up standard diagnostic CT. Diagnosis of lung cancer resulting from baseline low-dose CT screening and follow-up standard diagnostic CT is shown in Table [3](#Tab3){ref-type="table"}. There were no significant differences between low-dose CT and follow-upstandard diagnostic CT for lung cancer screening in all 11 criteria. The concordance rate for the diagnoses was approximately 80% (p \< 0.001) for all categories. Agreement of the evaluation of all categories in the final diagnosis exceeded 94% (p \< 0.001). Of the 19 subjects evaluated (9 men and 10 women; mean age, 60.6 years) there were 3 (2 men and 1 women; mean age, 54.3 years) malignant nodules and 16 (7 men and 9 women; mean age, 61.8 years) possibly benign nodules. The size of possibly benign nodules was 3 to 16 mm, and that of malignant nodules was 13 to 16 mm. The mean size of the four malignant nodules (14.6 mm) was larger than that of the 33 possibly benign nodules (6.8 mm).Table 3Lesion concordance rates between low-dose CT screening versus a follow-up standard diagnostic CTObserversCategoryABCDEAverage with lesionStatistically significant differenceSize of nodule (mm)100%100%100%100%100%100%p \< 0.001Pattern92%84%78%73%84%82%p \< 0.001Calcification100%100%100%100%95%99%p \< 0.001Boundary95%95%76%95%84%89%p \< 0.001Shape81%97%95%95%86%91%p \< 0.001Margin89%89%92%89%95%91%p \< 0.001Spiculation84%95%97%76%97%90%p \< 0.001Glomerulus97%95%100%92%84%94%p \< 0.001Indrawn pleura sign92%84%95%73%89%87%p \< 0.001Air bronchogram86%73%84%100%70%83%p \< 0.001Final diagnosis97%97%95%84%95%94%p \< 0.001

Evaluation concerning the nodules diagnosed as malignant accorded with the final diagnosis in the subjects. All physicians diagnosed 4 nodules in 3 subjects as malignant or suspected malignancy during follow-up examination. The four malignant nodules included an adenocarcinoma with cavitary lung lesion, pleural dissemination of an adenocarcinoma, and two bronchioloalveolar carcinomas, as shown in Figures [1](#Fig1){ref-type="fig"}, [2](#Fig2){ref-type="fig"}, [3](#Fig3){ref-type="fig"} and [4](#Fig4){ref-type="fig"}. Two patient (3 nodules) diagnoses were confirmed at surgery, and 1 patient was diagnosed with inoperable lung cancer.Figure 1**Low-dose CT screening image and follow-up diagnostic CT image.** Low-dose CT screening image with an image slice thickness and interval of 3 mm. Follow-up diagnostic CT image with an image slice thickness and interval of 1 mm. 57-year-old man with adenocarcinoma presenting as pure GGO with multiloculated cystic lesions in the right upper lobe. Result of pathological staging operable patient (T1N0M0).Figure 2**Low-dose CT screening image and follow-up diagnostic CT image.** Low-dose CT screening image with an image slice thickness and interval of 3 mm. Follow-up diagnostic CT image with an image slice thickness and interval of 1 mm. A 46-year-old man with pleural dissemination and adenocarcinoma presenting as a solid nodule with spiculation in the right upper lobe. Results of pathological staging in an operable patient (T4N2M1).Figure 3**Low-dose CT screening image and follow-up diagnostic CT image.** Low-dose CT screening image with a slice thickness and interval of 3 mm. Follow-up diagnostic CT image with an image slice thickness and interval of 1 mm. A 60-year-old woman with bronchioalveolar carcinoma (adenocarcinoma in situ) with mixed ground-glass opacity or pure ground-glass opacity in the right middle lobe (T1N0M0).Figure 4**Low-dose CT screening image and follow-up diagnostic CT image.** Low-dose CT screening image with a slice thickness and interval of 3 mm. Follow-up diagnostic CT image with an image slice thickness and interval of 1 mm. A 60-year-old woman with bronchioalveolar carcinoma (adenocarcinoma in situ) as mixed ground-glass opacity or pure ground-glass opacity in the right lower lobe (T1N0M0).

Dose to the internal organs under auto exposure control (AEC) was calculated by WAZA-ARI using the tube current obtained by follow-up standard diagnostic CT clinical data using the Toshiba Aquilion 16-MDCT (instead of the Toshiba Activity 16-MDCT). Radiation doses produced by lung CT with WAZA-ARI, ImPACT and CT-Expo indicated CTDIvol from the 16-slice Toshiba Medical System Activion are shown in Table [4](#Tab4){ref-type="table"}. The average dose-length product (DLP) was 59.8 mGy × cm for low-dose TSCT using 30 mA for clinical data in 2 men and 2 women. The average DLP was 99.7 mGy × cm for low-dose CT using 50 mA in 7 men and 8 women. With low-dose TSCT, the doses calculated by WAZA-ARI ranged between 2.7 to 5.2 mGy in the lung with an 1.5 to 2.8 mSv effective dose, and with a follow-up standard diagnostic CT calculated dose of 15.1 to 25.2 mGy in lung with an 9.4. to 13.8 mSv effective dose (ICRP 103). With the low-dose CT using ImPACT, the dose was 5.8 mGy in the lung with a 3.4 mSv effective dose (ICRP 130), but with the follow-up standard diagnostic CT, it was 23 mGy in lung with a 14.0 mSv effective dose (ICRP 103). Using CT-EXPO, the dose was 5.3 mGy with a 2.8 to 3.3-mSv effective dose (ICRP 60) with the low-dose CT, while the lung dose ranged between 21 and 21.2 mGy and the effective dose between 11 and 13 mSv (ICRP 60) with a follow-up standard diagnostic CT.Table 4**Estimated radiation dose of lung CT and CTDIvol with the 16-slice Toshiba medical systems aquilion**CT ScansLow-dose CT scanCT dose softWAZA-ARIImPACTCT-EXPOAuto exposure controlWithout AECWithout AECWithout AECSexMaleFemaleAverage adultMaleFemalemAs22.5 -- 37.522.5 - 37.537.537.537.5Lung (mGy)2.7 -- 4.63.1 -- 5.25.85.35.3Liver (mGy)2.7 -- 4.52.8 -- 4.74.84.74.8Breast (mGy)2.1 -- 3.52.2 -- 3.64.35.45.4ICRP103 (mSv)1.7 -- 2.81.5 -- 2.53.4\--ICRP60 (mSv)1.5 -- 2.51.3 -- 2.22.92.83.3DLP (mGy cm)84 -- 14071 -- 119168203203CTDIvol (mGy)2.1 -- 3.52.1 -- 3.53.53.33.3Average of DLP indicated value of 16 Toshiba rows CT (mGy x cm)59.8 (n = 4) -- 99.7(n = 15)CT ScansFollow--up standard diagnostic CT scanCT dose softWAZA--ARIImPACTCT--EXPOAuto exposure controlWith AECWithout AECWithout AECSexMaleFemaleAverage adultMaleFemalemAs150 (Max)150 (Max)150150150Lung (mGy)15.1 -- 22.117.9 -- 25.223.021.021.2Liver (mGy)18.6 -- 21.519.0 -- 22.519.018.719.3Breast (mGy)10.4 -- 17.011.6 -- 17.517.021.421.4ICRP103 (mSv)11.1 -- 13.89.4 -- 12.114.0\--ICRP60 (mSv)10.3 -- 12.58.5 -- 10.612.01113DLP (mGy cm)545 -- 679455 -- 574673810810CTDIvol (mGy)13.5 -- 16.813.3 -- 16.813.913.313.3Average of DLP indicated value of 16 Toshiba rows CT (mGy x cm)474.7 (n = 19)\*These radiation transport calculations were performed using the JM phantom with WAZA-ARI, and the MIRD-5 type phantom with ImPACT and the GSF phantom with CT-Expo. The JM phantom was constructed from CT images of a healthy Japanese male adult. The height and the weight were 171 cm and 65 kg, respectively. The MIRD-5 type phantom was a hermaphroditic adult. For the MIRD--5 type phantom, the height and the weight were 174 cm and 70 kg, respectively. For the GSF-ADAM phantom, the height and the weight were 170 cm and 70 kg, respectively. For the GSF-EVA phantom, the height and the weight were 160 cm and 60 kg, respectively.

Discussion {#Sec7}
==========

This is the most important finding in smaller nodules concerning improvement of survival. Many previous reports suggest the merit of early detection (Suzuki et al. [@CR25]), (National Cancer Institute [@CR19]). The problem is that low-dose CT for lung cancer screening creates an endemic of over-diagnosis through false-positives because of the high sensitivity and capacity for detection. The present study revealed that only a small number of low-dose CT scans used for lung cancer screening result in over-diagnosis compared to follow-up standard diagnostic CT. These features appear to be a specific characteristic of high-resolution CT.

According to the UNSCEAR (United Nations Scientific Committee on the Effects of Atomic Radiation) 2008 report, the effective dose of natural background radiation is 2.4 mSv ([@CR30]). A previous study reported that the background dose was 8.71 mGy in the lung, with an effective dose that ranged between 3.61 and 3.64 mSv (ICRP 60) using an anthropomorphic phantom, which is a model of a Japanese adult (RANDO; Alderson Research Laboratory, Salem, NY, USA, 163 cm height, 53 kg weight, without legs or arms) (Nishizawa et al. [@CR21]). The scanning parameters for lung cancer used for a single spiral CT were 120 kVp and 50 mA, a slice thickness of 10 mm, tube rotation speed of 2 s, a reconstructed image pitch of 10 mm, and a table speed of 10 mm/s. The effective dose of the low-dose CT ranged between 1.6 and 3.4 mSv. Comparison of effective doses between 10-mm slice thickness and 1-mm slice thickness was the same using modern CT units. In digital and analog chest X-ray systems, the radiation dose was extremely low, with averages ranging between 73 and 198 μGy. However, a phantom study that simulated Noguchi's Type A small adenocarcinoma revealed that the detection rate was very low by digital and analog chest X-ray systems (Ono et al. [@CR22]).

The present study indicated that low-dose CT screening provided diagnoses similar to standard diagnostic CT. The image quality of low-dose CT may be high enough for it to be used for the diagnosis of lung cancer as a method of repeated follow up. We suggest that low-dose CT for lung cancer screening should be used as a follow-up to standard diagnostic CT in place of standard-dose CT. The dose to the lung in low-dose CT is approximately one-sixth that of standard CT. Furthermore, it is suggested that in a high-risk population with the habit of cigarette smoking, annual low-dose CT for lung cancer screening is modestly recommended. It is important to create an effective low-dose CT protocol for lung cancer screening that takes into consideration both radiation dose and image quality.

Conclusion {#Sec8}
==========

Since small nodules in the lungs are very difficult to identify, periodic follow-up examinations are required for diagnosis of lung cancer. This study suggests that low-dose CT can be effectively used as a follow-up standard diagnostic CT in place of standard-dose CT in order to reduce the radiation dose.
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